Coatue
CAI · Health care

Caris Life Sciences

Tests tumor samples to help doctors pick cancer treatments.
No change
Coatue owns 9.8 million shares of Caris Life Sciences, worth about $175 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
9,819,992
Jun 30
9,819,992

The numbers

Shares they own
9,819,992
Value on Jun 30, 2026
$174,992,258
about $175 million
Share of their money
0.4%
less than $1 of every $100 · 33rd of 63
Price per share on Jun 30
$17.82
Kind
Shares
More about Caris Life Sciences
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works